IMA
ImageneBio, Inc.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$53.13M
P/E Ratio
—
EPS
$-10.13
Beta
—
52W High
$18.00
52W Low
$3.94
50-Day MA
$6.32
200-Day MA
$9.32
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About ImageneBio, Inc.
ImageneBio, Inc., a clinical-stage biotechnology company, develops therapeutics for immunological and inflammatory diseases. The company is headquartered in San Diego, California.
Fundamentals
| Revenue (TTM) | 800,000 |
| Gross Profit (TTM) | 800,000 |
| EBITDA | $-48.05M |
| Operating Margin | -6056.00% |
| Return on Equity | -68.90% |
| Return on Assets | -35.90% |
| Revenue/Share (TTM) | $0.15 |
| Book Value | $11.91 |
| Price-to-Book | 0.42 |
| Price-to-Sales (TTM) | 66.41 |
| EV/Revenue | 30.13 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $11.19M |
| Float | $6.27M |
| % Insiders | 15.83% |
| % Institutions | 49.52% |
Analyst Ratings
Consensus ($16.00 target)
2
Buy1
SellData last updated: 4/8/2026